Shares

8 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2022

Aug 15, 2022

SELL
$22.88 - $35.28 $14 Million - $21.5 Million
-609,786 Reduced 56.84%
462,949 $11.2 Million
Q4 2021

Feb 14, 2022

SELL
$29.66 - $44.0 $195,311 - $289,740
-6,585 Reduced 0.61%
1,072,735 $36.5 Million
Q3 2021

Nov 15, 2021

SELL
$43.09 - $82.26 $43.1 Million - $82.3 Million
-1,000,000 Reduced 48.09%
1,079,320 $46.5 Million
Q2 2021

Aug 16, 2021

SELL
$52.03 - $68.77 $35.4 Million - $46.8 Million
-680,000 Reduced 24.64%
2,079,320 $136 Million
Q1 2021

May 17, 2021

SELL
$43.96 - $55.99 $34.7 Million - $44.2 Million
-790,000 Reduced 22.26%
2,759,320 $145 Million
Q3 2020

Nov 16, 2020

SELL
$27.01 - $37.31 $27 - $37
-1 Reduced -0.0%
3,549,320 $103 Million
Q2 2019

Aug 14, 2019

BUY
$63.19 - $95.15 $63 - $95
1 Added 0.0%
3,549,321 $237 Million
Q3 2017

Nov 14, 2017

BUY
$91.08 - $104.49 $323 Million - $371 Million
3,549,320
3,549,320 $338 Million

Others Institutions Holding INGN

About Inogen Inc


  • Ticker INGN
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Medical Devices
  • Shares Outstandng 22,866,500
  • Market Cap $218M
  • Description
  • Inogen, Inc., a medical technology company, develops, manufactures, and markets portable oxygen concentrators to patients, physicians and other clinicians, and third-party payors in the United States and internationally. Its oxygen concentrators are used to deliver supplemental long-term oxygen therapy to patients suffering from chronic respirat...
More about INGN
Track This Portfolio

Track Novo Holdings Portfolio

Follow Novo Holdings and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Novo Holdings, based on Form 13F filings with the SEC.

News

Stay updated on Novo Holdings with notifications on news.